Investors | News | Contact Us | Join E-mail List | Jobs   

News Releases

Board of Directors

Audit Committee Charter

Compensation Committee Charter

Key People

Regulatory Filings

Stock Quote

 
  Key People at Guided Therapeutics
  Mark L. Faupel, Ph.D., President, Chief Executive Officer and Director.

Dr. Faupel has more than 20 years of experience as a senior executive developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Prior to coming to Guided Therapeutics in 1998 as Vice President of Business Development Guided Therapeutics, Dr. Faupel was a senior executive and co-founder of Biofield Corp.

He is the inventor on 15 U.S. patents and author of numerous scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet, Cancer, The European Journal of Radiology and Diabetes Technology & Therapeutics. He has served as a member of the European School of Oncology Task Force and on National Institutes of Health review panels. Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.

  Richard L. Fowler, Sr. Vice-president, Engineering.

Mr. Fowler is responsible for identifying new technical and business opportunities for Guided Therapeutics. These opportunities include new technologies, product lines or business acquisitions that are strategic to the Company's business. Mr. Fowler was formerly VP of Engineering at Guided Therapeutics where he oversaw the successful development of the BiliChek® Non-invasive Bilirubin Analyzer.

Mr. Fowler has more than 20 years experience in developing and bringing to market electro-optical devices. Prior to joining Guided Therapeutics, Mr. Fowler was President of Laser Atlanta Optics, Inc. where he developed and launched a new, low-cost laser range finder. He has also held management positions with GEC Avionics, Inc. and General Dynamics. Mr. Fowler holds a degree in Electrical Engineering from the University of Texas.

  Shabbir Bambot, Ph.D. Vice President, Research and Development.

Dr. Bambot is a Co-founder of Guided Therapeutics. He currently manages the development of the cervical cancer diagnostics product as well as other projects related to the Guided Therapeutics ISF sampling technology. He is responsible for identifying new technical and business opportunities for Guided Therapeutics. Dr. Bambot has several patents, publications and presentations in the areas of clinical monitoring and diagnostics and is the recipient of multiple NIH SBIR grants totaling in excess of $3.5 million for developing non-invasive diagnostic devices. He supports the clinical and regulatory process as well interacting with the FDA on regulatory filings and compliance. He is a frequent reviewer of scientific papers and NIH grant applications and chairs symposia at scientific meetings.

Dr. Bambot has a Ph.D. in Chemical Engineering from the University of Pittsburgh and has 15 years of experience in medical diagnostics product development. He has been instrumental in the successful launch of two point-of-care medical diagnostic products, the AVL/Roche OPTI 2® blood chemistry analyzer and the Guided Therapeutics BiliChek® Non-invasive Bilirubin Analyzer.

 
 



©2009 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service

cervical cancer, cervical cancer vaccine, spectrx, HPV, Pap test, pap smear, Human Papilloma virus, Human Papillomavirus, noninvasive, non-invasive, cancer detection, cancer products